NCT01542736View on ClinicalTrials.gov

Concurrent Carboplatin and Reduced Dose Craniospinal Radiation for Medulloblastoma and Primitive Neuroectodermal Tumor (PNET)

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Metastatic MedulloblastomaHigh Risk Supratentorial PNETMetastatic PNET
Interventions
DRUG

Carboplatin

Administered concurrently with craniospinal radiation.

DRUG

Vincristine

Administered concurrently with craniospinal radiation.

RADIATION

24 Gy

Craniospinal radiation.

Trial Locations (1)

80045

Children's Hospital Colorado, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT01542736 - Concurrent Carboplatin and Reduced Dose Craniospinal Radiation for Medulloblastoma and Primitive Neuroectodermal Tumor (PNET) | Biotech Hunter | Biotech Hunter